miR-106b and miR-93 abrogate TGFβ-induced apoptosis in GC cells by targeting the expression of BIM, encoding the pro-apoptotic protein BCL2-like 11, and thereby prevent apoptosis and cause tumor progression [26]. The gene discussed is BCL2L11; the disease is neoplasm.